UK markets close in 3 hours 58 minutes
  • FTSE 100

    -29.14 (-0.35%)
  • FTSE 250

    -47.78 (-0.23%)
  • AIM

    -0.91 (-0.11%)

    +0.0033 (+0.28%)

    +0.0001 (+0.01%)
  • Bitcoin GBP

    -939.28 (-1.68%)
  • CMC Crypto 200

    -5.14 (-0.34%)
  • S&P 500

    +13.28 (+0.25%)
  • DOW

    +66.22 (+0.17%)

    -0.56 (-0.71%)

    -9.60 (-0.40%)
  • NIKKEI 225

    -329.83 (-0.85%)

    -25.02 (-0.13%)
  • DAX

    -47.62 (-0.25%)
  • CAC 40

    -48.65 (-0.60%)

Trending tickers: Google | AstraZeneca | Hargreaves Lansdown | Broadcom

The latest investor updates on stocks that are trending on Tuesday

Google Makassar, South Sulawesi, Indonesia. 15th Aug, 2020. A child is playing a game on a cellphone with a picture of the Fortnite game on the computer screen in the background. Apple and Google announced their decision to remove Fortnite games from the App Store and Google Play app stores. Credit: Herwin Bahar/ZUMA Wire/Alamy Live News
Today's trending tickers: Google lost a bust up with Fortnite maker Epic Games over app store dominance. Photo: Herwin Bahar/ZUMA Wire/Alamy Live News (ZUMA Press, ZUMA Press, Inc.)

Google (GOOG)

Google chalked up its latest antitrust loss on Monday, following Fortnite maker Epic Games' claims the search engine used its dominant position to take advantage of app developers for profit. A jury in San Francisco reached the verdict unanimously in less than four hours.

The decision comes amid a slew of other potential antitrust issues for Google, including a trial set to focus on its dominance in search.

“The dominoes are going to start falling here,” Tim Sweeney, chief executive officer of Epic, said in an interview after the verdict.

Read more: LIVE: FTSE and European stocks higher as UK wage growth slows


Google shares finished 1.4% lower on Monday in US trading hours.

AstraZeneca (AZN.L)

Pharma company AstraZeneca's stock was up 1% in early trade on Tuesday as it said it had agreed to buy infectious disease vaccine developer Icosavax.

The deal is valued at up to $1.1bn (£876.6m) and is set to strengthen AstraZeneca's RSV vaccine portfolio.

Read more: Stocks that are trending today

It values Icosavax at $15 per share in cash at closing, plus a non-tradable contingent value right for up to $5 per share in cash if certain milestones are met.

The upfront payment of $15 a share represents a premium of about 43% to Icosavax's last close.

Hargreaves Lansdown (HL.L)

Hargreaves Lansdown shares slid more than 8% on Tuesday morning in London after the UK's Financial Conduct Authority (FCA) expressed concerns about investment platforms' charges to customers. Peer AJ Bell (AJB.L) also lost 6.8%.

Read more: Novo Nordisk is the 2023 Yahoo Finance Company of the Year

The FCA said it has written to 42 firms warning it could intervene to ensure fair pricing. It added that it had told platforms they have until 29 February to make changes.

Broadcom (AVGO)

Chipmaker Broadcom (AVGO) shares rose after Citi resumed coverage with a "Buy" rating. Broadcom's VMware deal and core strengths, plus AI opportunity, underpin Citi's bullish view.

The company is one of the manufacturers looking to profit from the AI computing boom.

Broadcom has gained more than 80% year-to-date and finished Monday's session 9% higher.

Watch: OpenAI’s Q* could become 'better than any human for certain activities' | The Crypto Mile

Download the Yahoo Finance app, available for Apple and Android.